Please assess the completion status of the following clinical trial:

Trial Title: Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Subjects who have, in previous Sangamo clinical trial received SB-728-T or SB-728mR-T, autologous T-cells genetically modified at the CCR5 gene by zinc finger nucleases and give consent to participate in the long-term follow-up study.~Exclusion Criteria:~There are no exclusion criteria for this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort 1 (Type: None): Long-term follow-up of HIV-infected subjects who received SB-728-T or SB-728mR-T in a previous trial.

Based on this trial design, predict the completion outcome and termination type (if applicable).